The blood test that may expose hidden cancer and chronic disease risk

You can have “normal” blood sugar and still be headed toward serious metabolic trouble.

That’s because a glucose reading tells you how much sugar is circulating in your blood. It doesn’t necessarily reveal how much insulin your body is pumping out to keep it there.

For years — sometimes decades — the pancreas may compensate for declining metabolic health by releasing more and more insulin.

Your blood sugar may continue to look acceptable.

Meanwhile, high insulin can promote fat storage, fuel inflammation and interfere with the way your cells produce energy.

And according to a new scientific paper, those changes may help create the metabolic conditions associated with cancer, cardiovascular disease, type 2 diabetes, obesity and neurodegeneration.

Now researchers are proposing a simple finger-prick measurement that could reveal more about this hidden metabolic state than blood sugar alone.

A wider window into your metabolic health

The proposed measurement is called the glucose ketone index, or GKI.

It compares two fuels circulating in your blood:

• Glucose, which comes largely from carbohydrates and is regulated by insulin
• Ketones, which your liver produces when your body begins burning stored fat for energy

By dividing the glucose measurement by the ketone measurement, GKI produces a number intended to reflect which fuel your body is relying on and how metabolically flexible it may be.

A higher GKI generally reflects more glucose and fewer ketones.

A lower GKI reflects lower glucose availability and greater ketone production — an indication that the body has shifted away from depending exclusively on sugar and is accessing more fat for fuel.

Researchers writing in Frontiers in Science believe this balance may provide a clearer picture of metabolic health than glucose readings or body weight alone. They propose that GKI could eventually help people monitor whether nutrition, fasting and exercise are moving their metabolism in a healthier direction.

That is important because the ability to switch efficiently between glucose and fat is one of the hallmarks of a healthy metabolism.

When that flexibility begins to disappear, insulin often sits at the center of the problem.

The insulin signal a glucose test may miss

Every time blood sugar rises, the pancreas releases insulin.

Insulin signals cells to take in glucose for immediate energy. It also tells the liver and muscles to store some of that fuel and directs excess energy into fat storage.

That is a normal and necessary process.

The problem begins when insulin remains elevated too often and for too long.

Cells can gradually become less responsive to its signal. The pancreas then releases even more insulin to force glucose out of the blood.

This compensating process can keep fasting glucose within an apparently normal range even as insulin resistance grows beneath the surface.

In other words, your glucose number may look reassuring precisely because insulin is working overtime.

This state of chronically elevated insulin — hyperinsulinemia — is associated with inflammation, increased fat production, reduced fat burning and metabolic pathways that can support abnormal cell growth.

The new GKI paper specifically identifies hyperinsulinemia, elevated glucose, inflammation and mitochondrial dysfunction as interconnected metabolic problems involved in cancer and other chronic diseases.

That is why focusing only on blood sugar may cause people to miss an important part of the picture.

What your mitochondria have to do with disease

Inside nearly every cell are tiny energy-producing structures called mitochondria.

Their job is to turn nutrients into ATP, the usable energy that powers cellular activity.

Healthy mitochondria can adapt to different fuel sources. They can use glucose, fatty acids and ketones depending on what is available and what the body needs.

But poor nutrition, inactivity, high glucose and persistently elevated insulin can contribute to mitochondrial dysfunction.

When mitochondria struggle to produce energy efficiently, they may generate excessive amounts of damaging molecules known as reactive oxygen species.

That can increase oxidative stress, inflammation, DNA damage and cellular instability.

The researchers behind the GKI roadmap point to mitochondrial dysfunction as a feature of many major chronic diseases, including:

• Cancer
• Cardiovascular disease
• Type 2 diabetes
• Obesity
• Dementia and other neurodegenerative conditions

They believe shifting metabolism away from chronic glucose dependence and toward greater ketone availability may reduce high blood sugar, high insulin, inflammation and excess reactive oxygen species while improving mitochondrial energy production.

That does not make ketones a magic cure.

But it does reinforce an important truth: The way your body produces and uses energy may influence whether your internal environment protects health or gives chronic disease an opportunity to take hold.

Cancer is a metabolic problem, too

Cancer is often discussed almost entirely as a genetic disease.

But cancer cells also have altered energy needs.

Many tumors consume large amounts of glucose to support their rapid growth. At the same time, high insulin can activate growth-related signaling pathways and help create an internal environment favorable to cancer development and progression.

The GKI was originally developed as a way to monitor nutritional adherence during metabolic approaches to cancer therapy. The new paper proposes expanding its use to provide a broader roadmap for cancer and chronic disease prevention and management.

Coauthor Professor Thomas Seyfried of Boston College emphasized that these diseases are not simply matters of genetic fate but are also heavily shaped by lifestyle and metabolic factors.

The proposed roadmap puts nutrition, exercise, glucose, ketones, insulin and mitochondrial function into one connected picture.

And that picture points to something conventional blood sugar testing can easily overlook:

You do not have to be diabetic for insulin to affect your future health.

Building a more disease-resistant body

Researchers are still working to determine which GKI ranges may be most useful for different conditions. But you do not need to wait for a new test to begin addressing the metabolic factors behind chronic disease.

The same fundamental habits that improve insulin sensitivity can also support healthier glucose levels, greater metabolic flexibility and better mitochondrial function:

• Reduce sugar and refined carbohydrates.
• Build meals around protein, healthy fats and fiber-rich whole foods.
• Avoid eating continuously throughout the day.
• Stay physically active and preserve muscle through resistance exercise.
• Get adequate sleep.
• Manage chronic stress, which can raise glucose and insulin.
• Maintain a healthy waist size and reduce excess visceral fat.

These steps can reduce the amount of insulin your body needs and help restore its ability to move between glucose and fat for energy.

But making meaningful changes begins with understanding what insulin may already be doing inside your body.

Long before blood sugar reaches the diabetic range, excess insulin may be encouraging weight gain, locking stored fat in place, increasing inflammation, straining the cardiovascular system and influencing pathways involved in cancer.

Yet most people are taught that insulin matters only if they have diabetes. That misunderstanding can allow metabolic dysfunction to progress quietly for years.

The bottom line: If you want to protect yourself against cancer, heart disease, diabetes and the other chronic illnesses threatening your future, you cannot afford to ignore insulin.

Sources

Simple test could help track metabolic health in cancer and chronic disease — EurekAlert

The glucose ketone index: a proposed quantitative biomarker to support cancer and chronic disease prevention and management — Frontiers in Science

FAQ: What the glucose ketone index may reveal about your health